Document is current
Any future updates will be listed below
-
Authors
Dres, Martin
Jung, Boris
Molinari, Nicolas
Manna, Federico
Dubé, Bruno-Pierre
Chanques, Gerald
Similowski, Thomas
Jaber, Samir
Demoule, Alexandre http://orcid.org/0000-0002-0432-7217
-
Funding
Funding for this research was provided by:
French Ministry of Health (2005 Programme Hospitalier de Recherche Clinique (PHRC))
Société de Réanimation de Langue Française (bourse de mobilité 2015)
European Respiratory Society (Short Term Fellowship program)
European Society of Intensive Care Medicine (2015 Bernhard Dräger Award)
Fondation pour la Recherche Médicale (FDM 20150734498)
Mitacs (Globalink Sorbonne Universités)
French Government. (investissement d'avenir ANR-10-AIHU 06)
- License Information
-
More Information
Article History
Received: 4 August 2019
Accepted: 16 October 2019
First Online: 21 November 2019
Ethics approval and consent to participate
: Human Research Ethics Committee approval for study 1 was given by the <i>Comité de Protection des Personnes Ile-de-France V</i>I (Paris) and for study 2 by the <i>Comité de Protection des Personnes Sud-Méditerranée</i> (Montpellier). Patients or next of kin gave informed consent.
: Not applicable.
: Martin Dres reports personal fees from Lungpacer, outside the submitted work. Boris Jung declares no competing interests. Nicolas Molinari declares no competing interests. Federico Manna declares no competing interests. Gerald Chanques reports personal fees from Aspen medical and personal fees from Orion pharma, during the conduct of the study. Samir Jaber declares no competing interests. Thomas Similowski reports receiving personal fees from Almirall France, personal fees from AstraZeneca France, corporate personal fees from Boehringer Ingelheim France, personal fees from GlaxoSmithKline France, personal fees from Invacare, personal fees from Mundipharma, personal fees and nonfinancial support from Novartis France, personal fees from Pfizer France, grants and personal fees from Pierre Fabre Médicaments, personal fees from Takeda, personal fees from Teva Pharma, and personal fees from Lungpacer Medical Inc., all outside the submitted work. Alexandre Demoule reports personal fees from Medtronic; grants, personal fees, and non-financial support from Philips; personal fees from Baxter; personal fees from Hamilton; personal fees and non-financial support from Fisher & Paykel; grants from French Ministry of Health; personal fees from Getinge; grants and personal fees from Respinor; and grants and non-financial support from Lungpacer. Brunop-Pierre Dubé received personal fees from Grifols, Boehringer Ingelheim and Roche, and has signed clinical research contracts with Sanofi, Roche and Boehringer Ingelheim.
